CM
OMED

Crestline Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Crestline Management’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-209,088
Closed -$483K – 281
2018
Q2 		$483K Buy
209,088
+8,134
+4% +$18.8K 0.05% 225
2018
Q1 		$639K Buy
200,954
+17,267
+9% +$54.9K 0.08% 181
2017
Q4 		$753K Buy
+183,687
New +$753K 0.08% 122